Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Inhibition of the activity of poly(ADP-ribose) polymerase in haemorrhagic shock

M. McDonald, H. Mota-Filipe, M. Abdelrahman, M. Threadgill, C. Thiemermann

Med Sci Monit 2003; 9(1): 41-0 :: ID: 15104

Abstract

There is good evidence that haemorrhagic shock is associated with the generation of reactive oxygen species (ROS) including superoxide anions and hydrogen peroxide [1]. It has been suggested that the activation of PARP plays a role in the cardiovascular failure associated with haemorrhagic shock [2], but there is little information regarding the role of PARP in the pathophysiology of the organ dysfunction/injury associated with haemorrhagic shock. Here we investigate the effects of several PARP inhibitors on the circulatory failure and the organ injury and dysfunction caused by severe haemorrhage and resuscitation in the anaesthetised rat. Male Wistar rats were anaesthetised with thiopentone sodium (120 mg/kg i.p.) and instrumented for the measurement of mean arterial pressure and heart rate. Haemorrhage (to lower blood pressure to ~50 mmHg for 90 min) and resuscitation (with blood and an equivalent volume of Ringers Lactate solution), resulted within 4 h in a delayed fall in blood pressure as well as in renal dysfunction, liver injury and dysfunction, pancreatic injury, and neuromuscular injury. Treatment of rats subjected to haemorrhage and resuscitation with the PARP inhibitors 3-aminobenzamide (10 mg/kg), nicotinamide (10 mg/kg), or 1,5 dihydroxyisoquinoline (ISO, 3 mg/kg) attenuated the multiple organ injury and dysfunction caused by haemorrhage and resuscitation. However, treatment with the vehicle for ISO (10% v/v DMSO) had a similar effect. As the beneficial effects of ISO (the most potent and specific PARP inhibitor) were, in part, due to its vehicle, further studies with the potent, specific and water soluble inhibitor of PARP activity, 5-aminoisoquinolinone (5-AIQ), were performed to ensure that the reduction by the agents of the multiple organ failure in haemorrhagic shock is indeed due to their ability to inhibit PARP activity. Administration (5 min prior to resuscitation of 5-AIQ (0.03 mg/kg i.v, or 0.3 mg/kg i.v.) reduced (in a dose-related fashion) the multiple organ injury and dysfunction, but did not affect the circulatory failure, associated with haemorrhagic shock. In conclusion, this study demonstrates that chemically distinct inhibitors of PARP activity attenuate the renal dysfunction, the hepatocellular injury and the pancreatic injury associated with severe haemorrhage and resuscitation. References: 1.Redl H, Gasser H, Schlag G, Marzi I: Involvement of oxygen radicals in shock related cell injury. Br Med Bull, 1993; 49: 556-65 2.Szabo C: Potential role of peroxynitrite-poly (ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock, 1998; 9: 341-344

Keywords: PARP, haemorrhage, multiple organ injury, Shock

Add Comment 0 Comments

Editorial

01 July 2026 : Editorial  

Editorial: The WHO Identifies Ebola Disease Due to Bundibugyo Virus as a Public Health Emergency of International Concern (PHEIC) as Vaccine Development Accelerates

Dinah V. Parums ORCID logo

DOI: 10.12659/MSM.954627

Med Sci Monit 2026; 32:e954627

0:00

In Press

Clinical Research  

Comparative Effectiveness of a Nurse-Led Care Model vs Usual Care in Rheumatoid Arthritis: A Longitudinal C...

Med Sci Monit In Press; DOI: 10.12659/MSM.953211  

Clinical Research  

Impact of Treatment Modality on Pain, Sexual Function, and Psychological Well-Being in Patients With Bartho...

Med Sci Monit In Press; DOI: 10.12659/MSM.952422  

Clinical Research  

Association Between Radiographic Knee Osteoarthritis, Pre-Fracture Mobility, and Hip Fracture Patterns in O...

Med Sci Monit In Press; DOI: 10.12659/MSM.952678  

Clinical Research  

Association Between Total Cholesterol–to–High-Density Lipoprotein Ratio and Gestational Hypertension: A Cas...

Med Sci Monit In Press; DOI: 10.12659/MSM.952395  

Most Viewed Current Articles

17 Jan 2024 : Review article   14,176,084

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,757,530

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,466,116

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   708,768

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750